Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

Similar articles for PubMed (Select 22490497)

1.

Gemifloxacin for the treatment of community-acquired pneumonia and acute exacerbation of chronic bronchitis: a meta-analysis of randomized controlled trials.

Zhang L, Wang R, Falagas ME, Chen LA, Liu YN.

Chin Med J (Engl). 2012 Feb;125(4):687-95. Erratum in: Chin Med J (Engl). 2013 Aug;126(16):3018. Matthew, Falagas E [corrected to Falagas, Matthew E].

PMID:
22490497
2.

Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.

Yoo BK, Triller DM, Yong CS, Lodise TP.

Ann Pharmacother. 2004 Jul-Aug;38(7-8):1226-35. Epub 2004 Jun 8. Review.

PMID:
15187209
3.

Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials.

Vardakas KZ, Siempos II, Grammatikos A, Athanassa Z, Korbila IP, Falagas ME.

CMAJ. 2008 Dec 2;179(12):1269-77. doi: 10.1503/cmaj.080358. Erratum in: CMAJ. 2009 Jan 6;180(1):79.

5.

Gemifloxacin: a new, potent fluoroquinolone for the therapy of lower respiratory tract infections.

File TM Jr, Tillotson GS.

Expert Rev Anti Infect Ther. 2004 Dec;2(6):831-43. Review.

PMID:
15566328
6.

Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis.

Siempos II, Dimopoulos G, Korbila IP, Manta K, Falagas ME.

Eur Respir J. 2007 Jun;29(6):1127-37. Epub 2007 Feb 14.

7.

Gemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis.

Jivcu C, Gotfried M.

Int J Chron Obstruct Pulmon Dis. 2009;4:291-300. Epub 2009 Aug 3. Review.

9.

Gemifloxacin: a new fluoroquinolone.

Blondeau JM, Missaghi B.

Expert Opin Pharmacother. 2004 May;5(5):1117-52.

PMID:
15155113
10.

A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.

Ball P, Mandell L, Patou G, Dankner W, Tillotson G.

Int J Antimicrob Agents. 2004 May;23(5):421-9. Review.

PMID:
15120718
11.

Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.

Appelbaum PC, Gillespie SH, Burley CJ, Tillotson GS.

Int J Antimicrob Agents. 2004 Jun;23(6):533-46. Review.

PMID:
15194123
12.

Gemifloxacin for community-acquired pneumonia.

Lode HM, Schmidt-Ionas M, Stahlmann R.

Expert Opin Investig Drugs. 2008 May;17(5):779-86. doi: 10.1517/13543784.17.5.779 . Review.

PMID:
18447602
13.

Short- versus long-course antibacterial therapy for community-acquired pneumonia : a meta-analysis.

Dimopoulos G, Matthaiou DK, Karageorgopoulos DE, Grammatikos AP, Athanassa Z, Falagas ME.

Drugs. 2008;68(13):1841-54.

PMID:
18729535
14.

Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults.

Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L.

Cochrane Database Syst Rev. 2012 Sep 12;9:CD004418. doi: 10.1002/14651858.CD004418.pub4. Review.

PMID:
22972070
16.

Antibiotics for community acquired pneumonia in adult outpatients.

Bjerre LM, Verheij TJ, Kochen MM.

Cochrane Database Syst Rev. 2004;(2):CD002109. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD002109.

PMID:
15106168
17.

Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis.

Falagas ME, Avgeri SG, Matthaiou DK, Dimopoulos G, Siempos II.

J Antimicrob Chemother. 2008 Sep;62(3):442-50. doi: 10.1093/jac/dkn201. Epub 2008 May 8.

19.

A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.

Wilson R, Schentag JJ, Ball P, Mandell L; 068 Study Group.

Clin Ther. 2002 Apr;24(4):639-52.

PMID:
12017408
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk